Search
for

    Sort by

    Research 151–180 of 1000+

    1. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases Cell · 2020 · 227 citations
    2. Safety of treatment options for spondyloarthritis: a narrative review Expert Opinion on Drug Safety · 2018 · 19 citations
    3. Medications Springer eBooks · 2016
    4. Contents Dermatologic Clinics · 2010
    5. Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway Frontiers in Pharmacology · 2019 · 58 citations
    6. Walnut fruit diaphragm ethanol extract ameliorates damage due to Triton WR‐1339‐induced hyperlipidemia in rats European Journal of Lipid Science and Technology · 2023 · 10 citations
    7. 778 Designing and utilizing a c-Rel specific bioassay in drug repurposing screen for HNSCC Journal of Investigative Dermatology · 2024
    8. Editor's Picks JEADV Clinical Practice · 2025
    9. Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review Clinical drug investigation · 2023 · 3 citations
    10. Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia) International journal of multidisciplinary research and analysis · 2023
    11. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis Acta dermato-venereologica · 2023 · 10 citations
    12. Janus Kinase Inhibitors in the Treatment of Alopecia Areata Prague Medical Report · 2023 · 2 citations
    13. Janus Kinase inhibitors in dermatology: a review Portuguese Journal of Dermatology and Venereology · 2023 · 1 citations
    14. Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L. Fitoterapia · 2010 · 61 citations
    15. Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature Journal of Dermatological Treatment · 2016 · 40 citations
    16. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations
    17. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    18. The use of phosphodiesterase inhibitors for the treatment of alopecia Journal of Dermatological Treatment · 2019 · 3 citations
    19. Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study Research Square (Research Square) · 2025
    20. El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura Revista Medicina Cutánea Ibero-Latino-Americana · 2022
    21. Small Molecule Inhibitors and Inflammatory Skin Diseases Suez Canal University Medical Journal · 2018
    22. Exosome Therapy from Hypoxia-treated Mesenchymal Stem Cells Reduces TNF-α and Increases VEGF Levels in Fluconazole-Induced Alopecia Model Molecular and Cellular Biomedical Sciences · 2025
    23. DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females International Journal of Scientific Research in Biological Sciences · 2025
    24. Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome DS Reviews of Research in Life Sciences · 2025
    25. Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis Frontiers in Pharmacology · 2025 · 3 citations
    26. Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors 2016 · 87 citations
    27. Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia PLOS ONE · 2012 · 22 citations
    28. Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus Biologics: Targets & Therapy · 2011 · 9 citations
    29. Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective Dermatology practical & conceptual · 2022 · 8 citations
    30. Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor Bioinformation · 2012 · 16 citations